Cargando…

Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation

BACKGROUND: Secreted frizzled-related proteins (SFRPs) are antagonists of the Wnt signaling pathway, which plays a central role in stem cell maintenance and differentiation of stem cells and hematopoietic progenitors. Epigenetic downregulation of SFRPs by promoter hypermethylation has been described...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennemann, Karla, Galm, Oliver, Wilop, Stefan, Schubert, Claudia, Brümmendorf, Tim H, Jost, Edgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502569/
https://www.ncbi.nlm.nih.gov/pubmed/22935201
http://dx.doi.org/10.1186/1868-7083-4-12
_version_ 1782250369657602048
author Bennemann, Karla
Galm, Oliver
Wilop, Stefan
Schubert, Claudia
Brümmendorf, Tim H
Jost, Edgar
author_facet Bennemann, Karla
Galm, Oliver
Wilop, Stefan
Schubert, Claudia
Brümmendorf, Tim H
Jost, Edgar
author_sort Bennemann, Karla
collection PubMed
description BACKGROUND: Secreted frizzled-related proteins (SFRPs) are antagonists of the Wnt signaling pathway, which plays a central role in stem cell maintenance and differentiation of stem cells and hematopoietic progenitors. Epigenetic downregulation of SFRPs by promoter hypermethylation has been described to be involved in the pathogenesis of hematopoietic malignancies. There is an association between aberrant Wnt signaling and the established cancer stem cell concept. In contrast to BCR-ABL1-positive chronic myeloid leukemia CML, BCR-ABL1-negative myeloproliferative neoplasms (Ph(-)MPN) are characterized by the frequent occurrence of an autoactivating mutation in the JAK2 tyrosine kinase (JAK2V617F) or other mutations in the JAK-STAT pathway. However, pathogenetic mechanisms of JAK2 mutated or unmutated Ph(-)MPN remain not completely understood. We determined the promoter methylation status of SFRP-1, -2, -4, and -5 in 57 MPN patient samples by methylation-specific polymerase chain reaction (PCR) (MSP). JAK2V617F was assessed by allele-specific PCR. RESULTS: Aberrant methylation among primary MPN samples was 4% for SFRP-1, 25% for SFRP-2, 2% for SFRP-4, and 0% for SFRP-5. Hypermethylation of SFRP-2, which was the most frequently hypermethylated gene in our study, could not be correlated to any specific MPN subtype. However, we detected a significant correlation between SFRP-2 methylation and presence of a JAK2V617F mutation (P = 0.008). None of the 10 CML samples showed any SFRP-methylation. CONCLUSIONS: Our data indicate that epigenetic dysregulation of the Wnt signaling pathway is a common event in MPN with aberrant methylation of at least one SFRP being detected in 25% of the primary patient samples and in 30% if only accounting for Ph(-)MPN. A significant correlation between SFRP-2 methylation and presence of JAK2V617F in our data supports the hypothesis that epigenetic dysregulation may be a complementary mechanism to genetic aberrations. Aberrant methylation of crucial stem cell maintenance genes seems to contribute to disease pathogenesis in Ph(-)MPN.
format Online
Article
Text
id pubmed-3502569
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35025692012-11-22 Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation Bennemann, Karla Galm, Oliver Wilop, Stefan Schubert, Claudia Brümmendorf, Tim H Jost, Edgar Clin Epigenetics Research BACKGROUND: Secreted frizzled-related proteins (SFRPs) are antagonists of the Wnt signaling pathway, which plays a central role in stem cell maintenance and differentiation of stem cells and hematopoietic progenitors. Epigenetic downregulation of SFRPs by promoter hypermethylation has been described to be involved in the pathogenesis of hematopoietic malignancies. There is an association between aberrant Wnt signaling and the established cancer stem cell concept. In contrast to BCR-ABL1-positive chronic myeloid leukemia CML, BCR-ABL1-negative myeloproliferative neoplasms (Ph(-)MPN) are characterized by the frequent occurrence of an autoactivating mutation in the JAK2 tyrosine kinase (JAK2V617F) or other mutations in the JAK-STAT pathway. However, pathogenetic mechanisms of JAK2 mutated or unmutated Ph(-)MPN remain not completely understood. We determined the promoter methylation status of SFRP-1, -2, -4, and -5 in 57 MPN patient samples by methylation-specific polymerase chain reaction (PCR) (MSP). JAK2V617F was assessed by allele-specific PCR. RESULTS: Aberrant methylation among primary MPN samples was 4% for SFRP-1, 25% for SFRP-2, 2% for SFRP-4, and 0% for SFRP-5. Hypermethylation of SFRP-2, which was the most frequently hypermethylated gene in our study, could not be correlated to any specific MPN subtype. However, we detected a significant correlation between SFRP-2 methylation and presence of a JAK2V617F mutation (P = 0.008). None of the 10 CML samples showed any SFRP-methylation. CONCLUSIONS: Our data indicate that epigenetic dysregulation of the Wnt signaling pathway is a common event in MPN with aberrant methylation of at least one SFRP being detected in 25% of the primary patient samples and in 30% if only accounting for Ph(-)MPN. A significant correlation between SFRP-2 methylation and presence of JAK2V617F in our data supports the hypothesis that epigenetic dysregulation may be a complementary mechanism to genetic aberrations. Aberrant methylation of crucial stem cell maintenance genes seems to contribute to disease pathogenesis in Ph(-)MPN. BioMed Central 2012-08-31 /pmc/articles/PMC3502569/ /pubmed/22935201 http://dx.doi.org/10.1186/1868-7083-4-12 Text en Copyright ©2012 Bennemann et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bennemann, Karla
Galm, Oliver
Wilop, Stefan
Schubert, Claudia
Brümmendorf, Tim H
Jost, Edgar
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
title Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
title_full Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
title_fullStr Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
title_full_unstemmed Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
title_short Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
title_sort epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the jak2v617f-mutation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502569/
https://www.ncbi.nlm.nih.gov/pubmed/22935201
http://dx.doi.org/10.1186/1868-7083-4-12
work_keys_str_mv AT bennemannkarla epigeneticdysregulationofsecretedfrizzledrelatedproteinsinmyeloproliferativeneoplasmscomplementsthejak2v617fmutation
AT galmoliver epigeneticdysregulationofsecretedfrizzledrelatedproteinsinmyeloproliferativeneoplasmscomplementsthejak2v617fmutation
AT wilopstefan epigeneticdysregulationofsecretedfrizzledrelatedproteinsinmyeloproliferativeneoplasmscomplementsthejak2v617fmutation
AT schubertclaudia epigeneticdysregulationofsecretedfrizzledrelatedproteinsinmyeloproliferativeneoplasmscomplementsthejak2v617fmutation
AT brummendorftimh epigeneticdysregulationofsecretedfrizzledrelatedproteinsinmyeloproliferativeneoplasmscomplementsthejak2v617fmutation
AT jostedgar epigeneticdysregulationofsecretedfrizzledrelatedproteinsinmyeloproliferativeneoplasmscomplementsthejak2v617fmutation